These new treatments have revolutionized cancer therapy in recent years by defeating the mechanisms by which tumors evade immune attack. Checkpoint inhibitors do so by preventing tumor cells from ...
Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies, and clues behind why ...
Celltrion announced on the 31st that its autoimmune disease treatment 'AVTOZMA' has received product approval from the U.S. Food and Drug Administration (FDA). The development name of AVTOZMA is ...